{"id":"https://openalex.org/W4281646440","doi":"https://doi.org/10.1111/bjh.18297","title":"Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR / CMWP of EBMT analysis","display_name":"Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR / CMWP of EBMT analysis","publication_year":2022,"publication_date":"2022-06-03","ids":{"openalex":"https://openalex.org/W4281646440","doi":"https://doi.org/10.1111/bjh.18297","pmid":"https://pubmed.ncbi.nlm.nih.gov/35658101","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9750039"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.18297","doi":"https://doi.org/10.1111/bjh.18297","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.18297","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9750039","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055922112","display_name":"Bhagirathbhai Dholaria","orcid":"https://orcid.org/0000-0003-2371-3655","observed_orcids":["https://orcid.org/0000-0003-2371-3655"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bhagirathbhai Dholaria","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, Tennessee, USA"],"raw_orcid":"https://orcid.org/0000-0003-2371-3655","affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043634148","display_name":"Aleksandar Radujkovic","orcid":"https://orcid.org/0000-0002-8543-5016","observed_orcids":["https://orcid.org/0000-0002-8543-5016"]},"institutions":[{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Aleksandar Radujkovic","raw_affiliation_strings":["Universit\u00e4tsklinikum Heidelberg  Heidelberg Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum Heidelberg  Heidelberg Germany","institution_ids":["https://openalex.org/I2802164966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023475751","display_name":"Noel Estrada\u2010Merly","orcid":"https://orcid.org/0009-0008-4479-8882","observed_orcids":["https://orcid.org/0009-0008-4479-8882"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noel Estrada\u2010Merly","raw_affiliation_strings":["Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061327412","display_name":"Tiarlan Sirait","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099689","display_name":"European Society for Blood and Marrow Transplantation","ror":"https://ror.org/014wq8057","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I4210099689"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Tiarlan Sirait","raw_affiliation_strings":["EBMT Leiden Study Unit, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EBMT Leiden Study Unit, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210099689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373092","display_name":"Soyoung Kim","orcid":"https://orcid.org/0000-0003-1404-0575","observed_orcids":["https://orcid.org/0000-0003-1404-0575"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Soyoung Kim","raw_affiliation_strings":["Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070420697","display_name":"Juan Carlos Hern\u00e1ndez\u2010Boluda","orcid":"https://orcid.org/0000-0002-4289-3113","observed_orcids":["https://orcid.org/0000-0002-4289-3113"]},"institutions":[{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Carlos Hern\u00e1ndez\u2010Boluda","raw_affiliation_strings":["Department of Hematology Hospital Cl\u00ednico Universitario  Valencia Spain"],"raw_orcid":"https://orcid.org/0000-0002-4289-3113","affiliations":[{"raw_affiliation_string":"Department of Hematology Hospital Cl\u00ednico Universitario  Valencia Spain","institution_ids":["https://openalex.org/I4210094406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006796325","display_name":"Tomasz Czerw","orcid":"https://orcid.org/0000-0003-3108-4035","observed_orcids":["https://orcid.org/0000-0003-3108-4035"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Tomasz Czerw","raw_affiliation_strings":["Maria Sk\u0142odowska\u2010Curie National Research Institute of Oncology  Gliwice Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sk\u0142odowska\u2010Curie National Research Institute of Oncology  Gliwice Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103189215","display_name":"Patrick John Hayden","orcid":"https://orcid.org/0000-0003-1374-4503","observed_orcids":["https://orcid.org/0000-0003-1374-4503","https://orcid.org/0000-0002-5396-9267"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]},{"id":"https://openalex.org/I4210154619","display_name":"St. James's Hospital","ror":"https://ror.org/04c6bry31","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210154619"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Patrick J. Hayden","raw_affiliation_strings":["Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin, Ireland","institution_ids":["https://openalex.org/I205274468","https://openalex.org/I4210154619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027546805","display_name":"Ankit J. Kansagra","orcid":"https://orcid.org/0000-0001-6901-0782","observed_orcids":["https://orcid.org/0000-0001-6901-0782"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ankit Kansagra","raw_affiliation_strings":["UT Southwestern Medical Center, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT Southwestern Medical Center, Dallas, Texas, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031812464","display_name":"Vincent T. Ho","orcid":"https://orcid.org/0000-0001-6839-3996","observed_orcids":["https://orcid.org/0000-0001-6839-3996"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent T. Ho","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062691289","display_name":"Taiga Nishihori","orcid":"https://orcid.org/0000-0002-2621-7924","observed_orcids":["https://orcid.org/0000-0002-2621-7924"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taiga Nishihori","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, Florida, USA"],"raw_orcid":"https://orcid.org/0000-0002-2621-7924","affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, Florida, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014618029","display_name":"Paul J. Shaughnessy","orcid":"https://orcid.org/0000-0003-4023-3864","observed_orcids":["https://orcid.org/0000-0003-4023-3864"]},"institutions":[{"id":"https://openalex.org/I4210101244","display_name":"Methodist Healthcare","ror":"https://ror.org/016d8zs37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210101244"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Shaughnessy","raw_affiliation_strings":["Sarah Cannon Transplant and Cellular Therapy Program Methodist Hospital, San Antonio, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Transplant and Cellular Therapy Program Methodist Hospital, San Antonio, Texas, USA","institution_ids":["https://openalex.org/I4210101244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart Scott","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108988001","display_name":"Ryotaro Nakamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryotaro Nakamura","raw_affiliation_strings":["City of Hope National Medical Center, Duarte, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope National Medical Center, Duarte, California, USA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085076031","display_name":"Bet\u00fcl Oran","orcid":"https://orcid.org/0000-0003-1264-5968","observed_orcids":["https://orcid.org/0000-0003-1264-5968"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betul Oran","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017327825","display_name":"Mohamed A. Kharfan\u2010Dabaja","orcid":"https://orcid.org/0000-0001-7394-5185","observed_orcids":["https://orcid.org/0000-0001-7394-5185"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohamed Kharfan\u2010Dabaja","raw_affiliation_strings":["Mayo Clinic, Jacksonville, Florida, USA"],"raw_orcid":"https://orcid.org/0000-0001-7394-5185","affiliations":[{"raw_affiliation_string":"Mayo Clinic, Jacksonville, Florida, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088962035","display_name":"Bipin N. Savani","orcid":"https://orcid.org/0000-0002-3304-9965","observed_orcids":["https://orcid.org/0000-0002-3304-9965"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bipin N. Savani","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017537622","display_name":"Donal P. McLornan","orcid":"https://orcid.org/0000-0003-1224-091X","observed_orcids":["https://orcid.org/0000-0003-1224-091X"]},"institutions":[{"id":"https://openalex.org/I1289784979","display_name":"University College Hospital","ror":"https://ror.org/00wrevg56","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289784979","https://openalex.org/I1340918713"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Donal McLornan","raw_affiliation_strings":["University College Hospital, London, UK"],"raw_orcid":"https://orcid.org/0000-0003-1224-091X","affiliations":[{"raw_affiliation_string":"University College Hospital, London, UK","institution_ids":["https://openalex.org/I1289784979"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050987906","display_name":"Ibrahim Yakoub\u2010Agha","orcid":"https://orcid.org/0000-0003-4524-8782","observed_orcids":["https://orcid.org/0000-0003-4524-8782"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4387152267","display_name":"Institute for Translational Research in Inflammation","ror":"https://ror.org/03qy9z186","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4387152267"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ibrahim Yakoub\u2010Agha","raw_affiliation_strings":["INSERM U1286, Infinite, CHU de Lille, Univ Lille, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1286, Infinite, CHU de Lille, Univ Lille, Lille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4387152267"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058862489","display_name":"Wael Saber","orcid":"https://orcid.org/0000-0002-6544-5815","observed_orcids":["https://orcid.org/0000-0002-6544-5815"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wael Saber","raw_affiliation_strings":["Department of Medicine, CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin  Milwaukee Wisconsin USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin  Milwaukee Wisconsin USA","institution_ids":["https://openalex.org/I204308271"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":22,"corresponding_author_ids":["https://openalex.org/A5055922112"],"corresponding_institution_ids":["https://openalex.org/I901861585"],"apc_list":{"value":4800,"currency":"USD","value_usd":4800},"apc_paid":null,"fwci":0.7273,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.70730195,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"198","issue":"4","first_page":"785","last_page":"789"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.27810001373291016,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.27810001373291016,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.25929999351501465,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.06800000369548798,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-haematopoietic-cell-transplantation","display_name":"allogeneic haematopoietic cell transplantation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/transplant-outcomes","display_name":"transplant outcomes","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cibmtr","display_name":"CIBMTR","score":0.7689999938011169},{"id":"https://openalex.org/keywords/ebmt-registry","display_name":"EBMT registry","score":0.6800000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7840864658355713},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.7195531725883484},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6096800565719604},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5797138810157776},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48821547627449036},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.45030224323272705},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43181559443473816},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.29862821102142334},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.2106042504310608},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015467","descriptor_name":"Leukemia, Neutrophilic, Chronic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015467","descriptor_name":"Leukemia, Neutrophilic, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/bjh.18297","doi":"https://doi.org/10.1111/bjh.18297","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.18297","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:35658101","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35658101","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:9750039","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9750039","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Br J Haematol","raw_type":"Text"},{"id":"pmh:oai:HAL:hal-04506353v1","doi":null,"is_oa":false,"landing_page_url":"https://lilloa.hal.science/hal-04506353","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Haematology, 2022, British Journal of Haematology, 198, pp.785-789. ⟨10.1111/bjh.18297⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:9750039","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9750039","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Br J Haematol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1360182821","display_name":null,"funder_award_id":"N00014-20-1-2832","funder_id":"https://openalex.org/F4320337345","funder_display_name":"Office of Naval Research"},{"id":"https://openalex.org/G3745029439","display_name":null,"funder_award_id":"HHSH250201700007C","funder_id":"https://openalex.org/F4320332175","funder_display_name":"Health Resources and Services Administration"},{"id":"https://openalex.org/G5804481516","display_name":null,"funder_award_id":"N00014\u201020\u20101\u20102705","funder_id":"https://openalex.org/F4320337345","funder_display_name":"Office of Naval Research"},{"id":"https://openalex.org/G6623594829","display_name":"Improving the Availability of Younger Unrelated Hematopoietic Stem Cell Donors","funder_award_id":"R01HL130388","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G6787592842","display_name":null,"funder_award_id":"UG1HL06924","funder_id":"https://openalex.org/F4320337350","funder_display_name":"National Eye Institute"},{"id":"https://openalex.org/G6979277618","display_name":null,"funder_award_id":"HHSH250201700006\u00a0C","funder_id":"https://openalex.org/F4320332175","funder_display_name":"Health Resources and Services Administration"},{"id":"https://openalex.org/G7792248381","display_name":"Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency","funder_award_id":"U01AI126612","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G8692236607","display_name":"Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation","funder_award_id":"R01CA215134","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000861695","display_name":"Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data","funder_award_id":"R01AI128775","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000891828","display_name":"A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research","funder_award_id":"U24CA076518","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306761","display_name":"Be The Match Foundation","ror":"https://ror.org/016cke005"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307769","display_name":"Astellas Pharma US","ror":"https://ror.org/05pw69n24"},{"id":"https://openalex.org/F4320308507","display_name":"Stanford University","ror":"https://ror.org/00f54p054"},{"id":"https://openalex.org/F4320308906","display_name":"St. Baldrick's Foundation","ror":"https://ror.org/03h1gea69"},{"id":"https://openalex.org/F4320309356","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320310786","display_name":"StemCyte","ror":"https://ror.org/00bekwh77"},{"id":"https://openalex.org/F4320310914","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244"},{"id":"https://openalex.org/F4320316519","display_name":"Angiocrine Bioscience","ror":"https://ror.org/02hpd7j03"},{"id":"https://openalex.org/F4320316659","display_name":"bluebird bio","ror":"https://ror.org/04vaq9436"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320319050","display_name":"Omeros Corporation","ror":"https://ror.org/01r5k6556"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320322336","display_name":"Kiadis Pharma","ror":"https://ror.org/021q58r72"},{"id":"https://openalex.org/F4320322359","display_name":"Kyowa Hakko Kirin","ror":"https://ror.org/0586k5242"},{"id":"https://openalex.org/F4320322422","display_name":"Miltenyi Biotec","ror":"https://ror.org/00qhe6a56"},{"id":"https://openalex.org/F4320328394","display_name":"Fonds de dotation CSL Behring pour la recherche","ror":"https://ror.org/04k6ep477"},{"id":"https://openalex.org/F4320331535","display_name":"CytoSen Therapeutics","ror":null},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332175","display_name":"Health Resources and Services Administration","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332194","display_name":"Johnson and Johnson","ror":"https://ror.org/03qd7mz70"},{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"},{"id":"https://openalex.org/F4320333299","display_name":"Biomedical Advanced Research and Development Authority","ror":"https://ror.org/029y69023"},{"id":"https://openalex.org/F4320333587","display_name":"Sanofi Genzyme","ror":null},{"id":"https://openalex.org/F4320333648","display_name":"Pharmacyclics","ror":"https://ror.org/03hm8w204"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337345","display_name":"Office of Naval Research","ror":"https://ror.org/00rk2pe57"},{"id":"https://openalex.org/F4320337350","display_name":"National Eye Institute","ror":"https://ror.org/03wkg3b53"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W2003393023","https://openalex.org/W2027093999","https://openalex.org/W2029535100","https://openalex.org/W2048331635","https://openalex.org/W2078879896","https://openalex.org/W2096094604","https://openalex.org/W2792424510","https://openalex.org/W2900644497","https://openalex.org/W2997715942","https://openalex.org/W3035282995"],"related_works":["https://openalex.org/W4388238840","https://openalex.org/W4283709275","https://openalex.org/W2909890633","https://openalex.org/W2997715942","https://openalex.org/W3096772509","https://openalex.org/W2027093999","https://openalex.org/W2096094604","https://openalex.org/W4223926370","https://openalex.org/W3169098949","https://openalex.org/W4311286082"],"abstract_inverted_index":{"Chronic":[0,217],"neutrophilic":[1],"leukaemia":[2],"(CNL)":[3],"is":[4,796,958,1007,1128,1162,1187,1243,1553],"a":[5,35,83,126,421,500,519,632,769,813,840,889,908,948,1327],"rare,":[6],"frequently":[7],"aggressive":[8],"Philadelphia":[9],"(Ph)-negative":[10],"myeloproliferative":[11],"neoplasm":[12],"(MPN).":[13],"Traditional":[14],"cytoreductive":[15],"therapies":[16,395,1031],"such":[17,872],"as":[18,873],"hydroxyurea":[19,385],"(hydroxycarbamide)":[20],"and":[21,27,90,98,114,176,182,206,216,250,264,266,272,320,351,381,408,476,541,592,613,623,644,665,718,725,749,807,836,859,875,920,929,1013,1027,1029,1077,1084,1093,1105,1121,1149,1152,1158,1169,1173,1175,1182,1208,1221,1234,1239,1271,1370,1405,1424,1429,1451,1482,1488],"interferon":[22],"have":[23,121,1500],"produced":[24],"mixed":[25],"results":[26,774],"disease":[28,69,336,346,544,688,932],"responses":[29],"are":[30,741,775,848,1021,1056],"generally":[31],"short-lived.1,":[32],"2":[33],"In":[34,82,696,824,991],"phase":[36],"II":[37],"study,":[38,910],"treatment":[39],"with":[40,55,80,244,281,371,518,611,727,761,793,804,1011,1053],"the":[41,72,87,99,107,162,166,177,191,196,207,222,254,270,278,308,321,368,382,435,556,575,697,705,755,779,825,852,952,962,969,1034,1060,1082,1087,1097,1110,1113,1119,1123,1137,1145,1153,1166,1176,1190,1199,1213,1225,1235,1248,1261,1266,1272,1342,1382,1388,1393,1396,1398,1402,1413,1419,1444,1452,1534,1557,1567,1579,1583],"JAK1/2":[42],"inhibitor":[43,404],"ruxolitinib":[44,409],"resulted":[45,630,721],"in":[46,58,125,147,171,277,294,347,355,363,377,388,420,434,478,537,549,631,710,722,790,864,877,894,939,974,1038,1065,1376],"overall":[47,109],"response":[48],"rates":[49,740],"of":[50,75,128,165,195,199,221,240,326,384,426,574,609,636,684,700,708,730,746,758,765,771,854,868,879,898,924,955,965,971,1036,1063,1086,1112,1140,1156,1178,1193,1202,1206,1216,1228,1264,1387,1391,1395,1400,1412,1504,1561],"65%":[51],"(n":[52,95,104,399,405,410,423,438,442,446,450,454,458,462,466,470,506,514,526,820],"=":[53,96,105,400,406,411,424,439,443,447,451,455,459,463,467,471,507,515,527,670,821],"21)":[54],"significant":[56],"reduction":[57],"CSF3R":[59,437,893],"allele":[60],"burden":[61],"among":[62,77],"responders.3":[63],"Despite":[64],"these":[65],"encouraging":[66],"early":[67,899],"results,":[68],"progression":[70],"was":[71,112,156,188,302,315,330,340,361,375,386,417,474,535,547,582,657,686,754,788,937,1521],"main":[73,756],"cause":[74,683,757],"death":[76,685],"patients":[78,129,144,225,243,350,370,380,540,731,766,792,803,831,1010,1434,1453],"treated":[79],"ruxolitinib.":[81],"population-based":[84],"analysis":[85,160,699,950,1528],"from":[86,248,253,300,324,567,783,828,995,1136,1518],"Surveillance,":[88],"Epidemiology,":[89],"End":[91],"Results":[92],"(SEER)":[93],"programme":[94],"73)":[97],"National":[100,197,208,1138,1142,1146,1154,1191,1195,1200,1204,1214,1218,1226,1230,1267,1389],"Cancer":[101,1143,1196],"Database":[102],"(NCDB)":[103],"121),":[106],"median":[108,298,312,322,571],"survival":[110,634,963],"(OS)":[111],"1.8":[113],"2.2":[115],"years":[116,319,599,651,674,735],"respectively.4":[117],"Previous":[118],"retrospective":[119,781],"studies":[120,847,1020,1052],"shown":[122],"durable":[123,723],"remission":[124,353],"subset":[127,422],"who":[130,257,1454],"received":[131,832,839],"allogeneic":[132],"haematopoietic":[133],"cell":[134,523],"transplantation":[135],"(allo-HCT).1,":[136],"5-8":[137],"The":[138,186,297,311,335,428,530,560,578,655,680,738,866,1041,1126,1373,1497,1526,1551],"allo-HCT":[139,261,301,329,339,610,653,709,863,880,902,966,1006,1037,1043,1064],"outcomes":[140,561,707,878,1035],"were":[141,145,267,275,291,432,497,562,604,810,943,1001],"poor":[142],"when":[143],"transplanted":[146],"accelerated":[148],"or":[149,283,510,817,1385,1408,1559],"blast-phase":[150,282,805],"CNL":[151,245,327,711,1012],"compared":[152,777],"to":[153,229,269,328,342,484,778,798,850,883,946,960,968,985,1003,1016,1023,1032,1046,1058,1081,1109,1435,1506,1533,1578],"chronic-phase.9":[154],"This":[155,359],"an":[157,987],"observational,":[158],"multicentre":[159],"using":[161,499,812],"data":[163,1445],"sets":[164],"Center":[167],"for":[168,180,202,235,307,489,862,891,896,1009,1049,1422,1432,1447,1514,1523,1556,1582],"International":[169],"Blood":[170,181,1150,1222,1423],"Marrow":[172,183,209,1268,1425],"Transplant":[173],"Research":[174,204,1180,1238],"(CIBMTR\u00ae)":[175],"European":[178,1420],"Society":[179,1421],"Transplantation":[184,1426],"(EBMT\u00ae).":[185],"protocol":[187],"approved":[189,1122],"by":[190,691,1131,1165,1189,1246,1566],"institutional":[192],"review":[193],"boards":[194],"Institutes":[198,1139,1192,1201,1215,1227,1390],"Health":[200,1133,1141,1167,1194,1203,1217,1229,1403],"Office":[201,1177],"Human":[203],"Protections,":[205],"Donor":[210,1269],"Program":[211],"(NMDP)":[212],"Institutional":[213],"Review":[214],"Board":[215],"Malignancies":[218],"Working":[219],"Party":[220],"EBMT.":[223],"All":[224],"gave":[226,1511],"informed":[227,1512],"consent":[228,1513],"use":[230,383,745],"their":[231,259,1448,1456],"anonymized":[232],"personal":[233],"information":[234,360,917,1564],"research":[236,1460,1489,1495],"purposes.":[237],"A":[238,977],"total":[239],"29":[241],"adult":[242],"[16":[246],"(55%)":[247],"CIBMTR":[249,271,576,1127,1535],"13":[251],"(45%)":[252],"EBMT":[255,273],"registry]":[256],"underwent":[258],"first":[260],"between":[262],"2000":[263],"2018":[265],"reported":[268,341,376,387,393,433],"registries":[274,716,1431],"included":[276,293,396],"study.":[279],"Cases":[280],"secondary":[284],"acute":[285],"myeloid":[286,870],"lymphoma":[287],"(AML)":[288],"before":[289],"transplant":[290,759,998],"not":[292,944,1380,1554],"this":[295,701,904,975,992,1377,1436,1524],"analysis.":[296,976],"follow-up":[299,572],"71":[303],"(range:":[304,317,332],"25\u2013161)":[305],"months":[306,566],"entire":[309],"cohort.":[310,577],"patient":[313,838],"age":[314],"58":[316],"33\u201372)":[318],"time":[323],"diagnosis":[325],"11":[331,348],"3\u201365)":[333],"months.":[334],"status":[337],"at":[338,564,589,597,641,649,662,672,733,1537],"be":[343,884,888,983,1047,1531,1576],"no":[344,1501],"response/stable":[345],"(38%)":[349],"complete":[352],"(CR)":[354],"four":[356,364,598,650,673,734],"(14%)":[357,365,693],"patients.":[358,366,391,427,481,552,941],"missing":[362,916,938,1573],"Among":[367],"25":[369],"available":[372,419],"information,":[373],"splenomegaly":[374],"eight":[378],"(28%)":[379],"19":[389],"(66%)":[390],"Other":[392],"pretransplant":[394],"hypomethylating":[397],"agent":[398],"4),":[401,444,456],"tyrosine":[402],"kinase":[403],"7)":[407],"7).":[412],"Data":[413],"on":[414,492,570,918],"somatic":[415,430],"mutations":[416,431,871],"only":[418],"9)":[425],"following":[429,1273],"database:":[436],"9),":[440],"ASXL1":[441,874],"DNMT3A":[445],"1),":[448,452,464],"IDH2":[449],"SETBP1":[453,876],"SRSF2":[457],"2),":[460],"CUX1":[461],"SF3B1":[465],"3)":[468],"RUNX1":[469],"2).":[472],"JAK2":[473],"tested":[475],"negative":[477],"17":[479],"(59%)":[480],"Please":[482,1549],"refer":[483],"Table":[485,553,1541,1543,1545,1547],"S2":[486,1544],"(Supporting":[487],"information)":[488],"full":[490],"details":[491,923],"genetic":[493],"abnormalities.":[494],"Most":[495,602],"transplants":[496,809],"performed":[498,811],"human":[501],"leukocyte":[502],"antigen":[503],"(HLA)-identical":[504],"sibling":[505,816],"12,":[508],"41%)":[509],"8/8":[511],"unrelated":[512,818],"donor":[513,819,843,861],"10,":[516],"34%)":[517],"peripheral":[520],"blood":[521,834],"stem":[522],"(PBSC)":[524],"graft":[525],"27,":[528],"93%).":[529],"myeloablative":[531],"conditioning":[532,856,925],"(MAC)":[533],"regimen":[534,748],"used":[536,548,1522],"14":[538],"(48%)":[539],"calcineurin-inhibitor-based":[542],"graft-versus-host":[543],"(GVHD)":[545],"prophylaxis":[546],"22":[550],"(76%)":[551],"1":[554],"shows":[555],"detailed":[557],"baseline":[558],"characteristics.":[559],"censored":[563],"48":[565],"allo-HCT,":[568],"based":[569],"duration":[573],"non-relapse":[579],"mortality":[580],"(NRM)":[581],"10.3%":[583],"[95%":[584],"confidence":[585],"interval":[586],"(CI):":[587],"2\u201324.1]":[588],"one":[590,607,642,663,763,837],"year":[591,608,643,664,770],"13.8%":[593],"(95%":[594,620,625,638,646,659,667],"CI:":[595,621,626,639,647,660,668],"3.7\u201328.9)":[596],"after":[600,652,736,901],"allo-HCT.":[601,737],"relapses":[603],"seen":[605],"within":[606,768],"one-":[612],"four-year":[614],"relapse":[615,753,900],"incidence":[616],"(RI)":[617],"being":[618],"31%":[619],"15.5\u201349.2)":[622],"34.5%":[624],"18.2\u201352.9)":[627],"respectively.":[628,654],"Allo-HCT":[629,720],"disease-free":[633],"(DFS)":[635],"58.6%":[637],"40.5\u201375.6)":[640],"51.7%":[645],"33.8\u201369.4)":[648],"OS":[656,726,787],"69%":[658],"51.3\u201384.2)":[661],"55.2%":[666],"37.1":[669],"72.5)":[671],"respectively":[675],"(Table":[676,694],"S4;":[677],"Figure":[678],"1).":[679],"most":[681,808,940],"common":[682],"primary":[687],"(57%),":[689],"followed":[690],"infection":[692],"S3).":[695],"largest":[698],"kind,":[702],"we":[703,801,1000],"report":[704],"long-term":[706,1017],"combing":[712],"two":[713,830,996],"large":[714],"international":[715,979,997],"(CIBMTR":[717],"EBMT).":[719],"DFS":[724],"nearly":[728],"half":[729],"surviving":[732],"NRM":[739],"acceptable":[742],"despite":[743],"predominant":[744],"MAC":[747],"PBSC":[750],"graft.":[751,845],"Disease":[752],"failure":[760],"around":[762],"third":[764],"relapsing":[767],"transplant.":[772],"Our":[773],"favourable":[776],"previous":[780],"cohort":[782],"Japan":[784],"where":[785],"one-year":[786],"40%":[789],"five":[791],"CNL.":[794,865,1040,1050,1066],"It":[795,957,1161],"important":[797],"note":[799],"that":[800,1005],"excluded":[802],"CNL,":[806],"well":[814],"HLA-matched":[815],"22,":[822],"76%).":[823],"case":[826],"series":[827],"Japan,":[829],"cord":[833],"grafts":[835],"related":[841],"haploidentical":[842],"marrow":[844,895],"Further":[846,1019],"needed":[849,1022,1057],"explore":[851],"role":[853,890],"reduced-intensity":[855],"(RIC)":[857],"regimens":[858],"alternative":[860],"impact":[867],"concurrent":[869],"also":[881,1163,1244,1442],"remains":[882,1045],"determined.":[885],"There":[886],"may":[887,982,1014],"monitoring":[892],"detection":[897],"although":[903],"requires":[905],"validation.10":[906],"Being":[907],"registry-based":[909],"our":[911],"study":[912,994,1437],"had":[913],"limitations":[914],"including":[915],"pre-":[919,1028],"posttransplant":[921,1030],"therapies,":[922],"regimen,":[926],"molecular":[927],"markers":[928],"measurable":[930],"residual":[931],"status.":[933],"Information":[934],"about":[935],"GVHD":[936],"We":[942,1416,1441],"able":[945,1002],"conduct":[947],"multivariate":[949],"given":[951],"small":[953],"number":[954],"cases.":[956],"difficult":[959],"ascertain":[961],"benefit":[964,1062],"due":[967],"lack":[970],"non-HCT":[972],"control":[973],"larger":[978],"collaborative":[980,993],"effort":[981],"required":[984],"achieve":[986],"adequate":[988],"sample":[989],"size.":[990],"registries,":[999],"demonstrate":[1004],"feasible":[1008],"lead":[1015],"survival.":[1018],"define":[1024],"optimal":[1025,1042],"timing":[1026],"improve":[1033],"chronic-phase":[1039],"platform":[1044],"defined":[1048],"Comparative":[1051],"non-transplant":[1054],"cohorts":[1055],"determine":[1059],"relative":[1061],"Bhagirathbhai":[1067,1099],"Dholaria,":[1068,1100],"Aleksandar":[1069],"Radujkovic,":[1070],"Donal":[1071,1101],"McLornan,":[1072,1102],"Ibrahim":[1073],"Yakoub-Agha,":[1074],"Wael":[1075,1103],"Saber":[1076,1104],"Noel":[1078,1089,1106],"Estrada-Merly":[1079,1107],"contributed":[1080,1108,1455],"conception":[1083],"design":[1085],"study;":[1088],"Estrada-Merly,":[1090],"Tiarlan":[1091],"Sirait":[1092],"Soyoung":[1094],"Kim":[1095],"analysed":[1096],"data;":[1098],"writing":[1111],"manuscript;":[1114],"all":[1115,1418],"authors":[1116,1499],"critically":[1117],"reviewed":[1118],"manuscript":[1120],"final":[1124,1527],"version.":[1125],"supported":[1129,1164],"primarily":[1130],"Public":[1132],"Service":[1134],"U24CA076518":[1135],"Institute,":[1144,1151],"Heart,":[1147,1219],"Lung,":[1148,1220],"Institute":[1155,1197,1205,1223,1232],"Allergy":[1157,1207],"Infectious":[1159,1209],"Diseases.":[1160],"Resources":[1168,1404],"Services":[1170,1406],"Administration":[1171],"(HHSH250201700006C":[1172],"HHSH250201700007C)":[1174],"Naval":[1179],"(N00014-20-1-2705":[1181],"N00014-20-1-2832).":[1183],"Additional":[1184],"federal":[1185],"support":[1186],"provided":[1188,1245],"(R01CA215134),":[1198],"Diseases":[1210],"(R01AI128775,":[1211],"U01AI126612),":[1212],"(R01HL130388),":[1224],"Eye":[1231],"(UG1HL06924),":[1233],"Biomedical":[1236],"Advanced":[1237],"Development":[1240],"Authority.":[1241],"Support":[1242],"Be":[1247],"Match":[1249],"Foundation,":[1250,1258],"Boston":[1251],"Children's":[1252],"Hospital,":[1253],"Dana":[1254],"Farber,":[1255],"St.":[1256],"Baldrick's":[1257],"Stanford":[1259],"University,":[1260],"Medical":[1262],"College":[1263],"Wisconsin,":[1265],"Program,":[1270],"commercial":[1274],"entities:":[1275],"Actinium":[1276],"Pharmaceuticals,":[1277,1322],"Inc.,":[1278,1282,1284,1292,1303,1315,1323,1348,1355,1358,1360],"Adienne":[1279],"SA,":[1280],"AlloVir,":[1281],"Amgen,":[1283],"Angiocrine":[1285],"Bioscience,":[1286],"Astellas":[1287],"Pharma":[1288],"US,":[1289],"Bluebird":[1290],"Bio,":[1291],"Bristol":[1293],"Myers":[1294],"Squibb":[1295],"Co.,":[1296,1306,1345],"Celgene":[1297],"Corp.,":[1298,1340],"CSL":[1299],"Behring,":[1300],"CytoSen":[1301],"Therapeutics,":[1302,1310,1335],"Daiichi":[1304],"Sankyo":[1305],"Ltd.,":[1307,1313],"ExCellThera,":[1308],"Fate":[1309],"Gamida":[1311,1470],"Cell,":[1312,1471],"Genentech":[1314],"Incyte":[1316],"Corporation,":[1317,1351,1353],"Janssen/Johnson":[1318],"&":[1319,1338],"Johnson,":[1320],"Jazz":[1321],"Kiadis":[1324],"Pharma,":[1325,1367],"Kite,":[1326],"Gilead":[1328],"Company,":[1329],"Kyowa":[1330],"Kirin,":[1331],"Legend":[1332],"Biotech,":[1333],"Magenta":[1334],"Merck":[1336],"Sharp":[1337],"Dohme":[1339],"Millennium,":[1341],"Takeda":[1343,1366],"Oncology":[1344],"Miltenyi":[1346],"Biotec,":[1347],"Novartis":[1349],"Pharmaceuticals":[1350],"Omeros":[1352],"OncoImmune,":[1354],"Orca":[1356],"Biosystems,":[1357],"Pfizer,":[1359,1465],"Pharmacyclics,":[1361],"LLC,":[1362],"Sanofi":[1363],"Genzyme,":[1364],"StemCyte,":[1365],"Vor":[1368],"Biopharma":[1369],"Xenikos":[1371],"BV.":[1372],"views":[1374],"expressed":[1375],"article":[1378],"do":[1379],"reflect":[1381],"official":[1383],"policy":[1384],"position":[1386],"Health,":[1392],"Department":[1394,1399],"Navy,":[1397],"Defence,":[1401],"Administration,":[1407],"any":[1409,1562],"other":[1410,1498,1519],"agency":[1411],"US":[1414],"government.":[1415],"thank":[1417,1443],"(EBMT)":[1427],"centres":[1428],"national":[1430],"contributing":[1433],"(Supplementary":[1438],"Appendix":[1439,1539],"material).":[1440],"managers":[1446],"excellent":[1449],"work":[1450],"data.":[1457],"B.":[1458],"Dholaria\u2014Institutional":[1459],"funding:":[1461],"Takeda,":[1462],"Janssen,":[1463],"Angiocrine,":[1464],"Poseida,":[1466],"MEI;":[1467],"consultancy/adviser:":[1468],"Jazz,":[1469],"MJH":[1472],"BioScience,":[1473],"Arivan":[1474],"Research,":[1475],"BEAM":[1476],"therapeutics.":[1477],"D.":[1478],"McLornan\u2014Jazz:":[1479],"speaker":[1480,1486,1492],"bureau":[1481,1487],"advisory":[1483],"boards,":[1484],"Novartis:":[1485],"funding,":[1490],"AbbVie:":[1491],"bureau,":[1493],"BMS-Celgene:":[1494],"funding.":[1496],"relevant":[1502],"conflicts":[1503],"interest":[1505],"disclose.":[1507],"Patients":[1508],"and/or":[1509],"guardian(s)":[1510],"research.":[1515],"No":[1516],"material":[1517],"sources":[1520],"manuscript.":[1525],"dataset":[1529],"will":[1530],"posted":[1532],"website":[1536],"https://www.cibmtr.org/ReferenceCenter/PubList/PubDsDownload/Pages/default.aspx.":[1538],"S1":[1540,1542],"S3":[1546],"S4":[1548],"note:":[1550],"publisher":[1552],"responsible":[1555],"content":[1558],"functionality":[1560],"supporting":[1563],"supplied":[1565],"authors.":[1568],"Any":[1569],"queries":[1570],"(other":[1571],"than":[1572],"content)":[1574],"should":[1575],"directed":[1577],"corresponding":[1580],"author":[1581],"article.":[1584]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-06-13T00:00:00"}